CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Jason LesterNayyer Iqbal

Abstract

Surgery is the standard treatment for stage I, II and certain stage IIIA non-small cell lung cancers (NSCLC). A proportion of patients with technically operable NSCLC do not undergo surgery because of significant co-morbidity or refusal, and radical radiotherapy may cure some of these patients. Between April 1997 and March 2000, 135 consecutive patients with stage I-IIIB NSCLC were treated with CT-planned accelerated hypofractionated radical radiotherapy to a dose of 50-55Gy in 15-20 fractions over 3-4 weeks at a single centre. The 2-year overall and cause-specific survival for all patients was 44.4% (95% CI = 36.8, 53.7) and 47.8% (95% CI = 39.9, 57.3) respectively. Overall median survival was 21 months (95% 18, 28). There were no reports of severe acute or late treatment-related toxicities. These results compare favourably with previously published studies on radical radiotherapy in NSCLC, suggesting this may be an effective and safe technique.

References

Nov 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M BollaC Vrousos
Jan 1, 1988·Acta Oncologica·H R WithersB Maciejewski
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Oct 23, 1997·International Journal of Radiation Oncology, Biology, Physics·L B MarksM Anscher
Sep 16, 1999·International Journal of Radiation Oncology, Biology, Physics·M V GrahamC A Perez
Aug 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J Armstrong, C McGibney

❮ Previous
Next ❯

Citations

Apr 16, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Dongryul OhHongryull Pyo
Jun 3, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lucyna KepkaKrzysztof Bujko
Apr 28, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Pierluigi BonfiliVincenzo Tombolini
May 1, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·L KepkaB Jeremic
Dec 30, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·L S PembertonM Q Hatton
Jan 24, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Fergus R MacbethUNKNOWN International Atomic Energy Agency
Feb 3, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Lucyna KepkaUNKNOWN International Atomic Energy Agency (IAEA)
Jun 21, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gijsbert W P M KramerUNKNOWN EORTC-Lung Cancer Group
Oct 8, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Omar S DinMatthew Q F Hatton
Aug 25, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·N Rodríguez de DiosM Algara
Oct 4, 2018·Journal of Medical Imaging and Radiation Oncology·Andrew D NguyenShalini K Vinod
Jun 6, 2007·Multiple Sclerosis : Clinical and Laboratory Research·F G MastronardiM A Moscarello
Jun 30, 2006·Hormone Research·S BallottiM de Martino
Jul 5, 2011·Annual Review of Genomics and Human Genetics·Isaac S Chan, Geoffrey S Ginsburg
Jan 13, 2012·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Thiago Fonseca-SilvaAndré Luiz Sena Guimarães
Feb 22, 2021·Seminars in Radiation Oncology·Anna Wrona, Francoise Mornex

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
P C CheungS Zhou
International Journal of Radiation Oncology, Biology, Physics
Patrick C F CheungCyril E Danjoux
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Pierre ThirionJohn Armstrong
© 2022 Meta ULC. All rights reserved